Without insurance the long-term sustainability of nanotechnology is questionable, but insurance companies are encumbered by their institutional memory of losses from the asbestos crisis and the absence of suitable actuarial models to measure the potential risks of nanotechnology. Here we propose a framework that supports the transfer of nanomaterial production risk to the insurance sector.